about
Intracochlear drug delivery in combination with cochlear implants : Current aspects[Intracochlear drug delivery in combination with cochlear implants : Current aspects].Optimizing atoh1-induced vestibular hair cell regeneration.Hearing preservation in cochlear implant surgery.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.Vestibular regeneration--experimental models and clinical implications.Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy.Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.Viral vector tropism for supporting cells in the developing murine cochlea.Localized cell and drug delivery for auditory prostheses.Inner ear drug delivery for auditory applications.Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.The molecular basis of neurosensory cell formation in ear development: a blueprint for hair cell and sensory neuron regeneration?Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.Electric-acoustic stimulation of the auditory system: a review of the first decade.Gene transfer in inner ear cells: a challenging race.The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution.A microfluidic reciprocating intracochlear drug delivery system with reservoir and active dose control.
P2860
Q30313632-A353C1C1-4648-4EA0-91BC-E18D73322D3DQ30313814-875714B2-7589-466D-B49C-B3E4AAAD07C6Q30364993-D4AFBB0F-E88A-411F-AD06-C9BE6246FBAEQ30367368-3F06E4E0-DD29-48B1-9A1A-4DF6A6C1E811Q30411312-69790723-7852-4057-BD39-5AAE613E1BE2Q30415880-CF646D1C-F0E9-44F3-B4EF-C89E380A8906Q30440245-F39D0520-83C8-49C8-BC99-62F626887000Q30440908-908E5853-D0C3-455F-BD5E-DACDD4AE787FQ30466103-4EF7F965-8295-46CC-989E-3DF6BB3C17C2Q30475885-20C7DCCF-FCF9-4DE0-8D91-0F151B43851DQ30484636-9F85355F-66D2-4953-BCF1-77A6DCF2DA0EQ34295662-F0CB9EFA-2E1C-4D9C-A6D5-6DDADE5A0AF5Q36660562-C34E96FE-DE40-44F4-B88D-044A10A57340Q37830908-538C608F-88B4-4AF2-9475-E5166D768B6AQ37878792-24EB6545-F50D-4B0A-9ACD-02DC05414D56Q38022141-1F9A72B0-A782-4612-82F0-3007392FC27BQ39110356-4E1D0A5A-CA07-4FE2-BB95-4FFD2D1B4D04Q41891299-C4581384-570E-4713-84A5-BBCEF8D456F6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Drug delivery to the inner ear using gene therapy.
@ast
Drug delivery to the inner ear using gene therapy.
@en
type
label
Drug delivery to the inner ear using gene therapy.
@ast
Drug delivery to the inner ear using gene therapy.
@en
prefLabel
Drug delivery to the inner ear using gene therapy.
@ast
Drug delivery to the inner ear using gene therapy.
@en
P2093
P1476
Drug delivery to the inner ear using gene therapy
@en
P2093
Douglas E Brough
Mark Praetorius
P304
P356
10.1016/J.OTC.2004.05.001
P577
2004-10-01T00:00:00Z